Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)

NCT01949324 is registered in ClinicalTrials.gov with Neurotech Pharmaceuticals as lead sponsor.

NCT NCT01949324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01949324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Multicenter Randomized Clinical Trial of Ciliary Neurotrophic Factor (CNTF) for Macular Telangiectasia Type 2 (MacTel)
Lead sponsor
Neurotech Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2014
Completion date
May 22, 2017
Enrollment
67 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

macular telangiectasia type 2